KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Gross Profit: 2009-2025

Historic Gross Profit for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $432.2 million.

  • Charles River Laboratories International's Gross Profit fell 2.01% to $432.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 17.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 7.05% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Gross Profit of $432.2 million as of Q3 2025, which was down 3.36% from $447.3 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Gross Profit high stood at $695.0 million for Q4 2023, and its period low was $361.8 million during Q3 2023.
  • In the last 3 years, Charles River Laboratories International's Gross Profit had a median value of $432.2 million in 2025 and averaged $438.5 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Gross Profit spiked by 42.32% in 2021, and later slumped by 45.17% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Gross Profit stood at $437.0 million in 2021, then climbed by 13.68% to $496.7 million in 2022, then surged by 39.91% to $695.0 million in 2023, then slumped by 45.17% to $381.0 million in 2024, then decreased by 2.01% to $432.2 million in 2025.
  • Its last three reported values are $432.2 million in Q3 2025, $447.3 million for Q2 2025, and $406.7 million during Q1 2025.